Domain Therapeutics
PrivateLast Round
Series A
May 10, 2022
Total Funding Raised
$54.48M
Company Overview
Domain Therapeutics is a biopharmaceutical company focused on developing medical therapeutics for central nervous system diseases and cancer through the discovery of new drug candidates targeting G protein-coupled receptors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Domain Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Domain Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 10, 2022 | ||||
| Debt | Jan 13, 2020 | ||||
| VC Round | May 28, 2019 | ||||
| Grant | Apr 14, 2014 | ||||
| Series A | Jul 18, 2012 | ||||
Grant | Jan 30, 2012 |
Key People
Founding team and executive leadership
Domain Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Idinvest Partners | Seed |
| Alsace Inter Regio Fonds d’Investissement | Seed |
| 3B FUTURE Health Fund | Series A |
| Caisse d'Epargne | Debt |
| Banque Populaire | Debt |
| Bpifrance | Debt |
| Turenne Groupe | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
Jean-Marie Cuillerot, M.D. appointed as new CMO.
Domain Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Domain Therapeutics's valuation, stock price, and market status.
